CNBC July 16, 2024
Good morning! Novo Nordisk‘s blockbuster diabetes drug Ozempic may have more to offer beyond regulating blood sugar and promoting weight loss.
That’s according to a new University of Oxford analysis published last week, which found that Ozempic could lower the risk of dementia and a range of other mental problems compared with other existing treatments for patients with diabetes. What’s more, researchers found that Ozempic cut nicotine dependence in those patients.
Those findings add to the growing list of potential health benefits of Ozempic and other highly popular GLP-1 treatments, such as Novo Nordisk’s weight loss injection Wegovy and drugs from rival Eli Lilly.
Large clinical trials have already shown that semaglutide, the active ingredient in Ozempic and...
Today's Sponsors
Today's Sponsor